Health Valuation
| HPP Stock | 0.04 0.00 0.00% |
Health seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Health and Plant from evaluating the firm fundamentals such as return on equity of -0.34, and Return On Asset of -0.0758 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Health's price fluctuation is very steady at this time. Calculation of the real value of Health and Plant is based on 3 months time horizon. Increasing Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Health's intrinsic value may or may not be the same as its current market price of 0.04, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.042 | Real 0.0353 | Hype 0.042 | Naive 0.042 |
The intrinsic value of Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Health and Plant helps investors to forecast how Health stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Health more accurately as focusing exclusively on Health's fundamentals will not take into account other important factors: Health Total Value Analysis
Health and Plant is currently projected to have takeover price of 2.96 M with market capitalization of 5.16 M, debt of 112 K, and cash on hands of 3.74 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.96 M | 5.16 M | 112 K | 3.74 M |
Health Investor Information
About 83.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. Health and Plant recorded a loss per share of 0.05. The entity last dividend was issued on the 13th of May 2013. The firm had 1:4 split on the 1st of May 2012. Health and Plant is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Health has an asset utilization ratio of 0.34 percent. This implies that the Company is making USD0.003353 for each dollar of assets. An increasing asset utilization means that Health and Plant is more efficient with each dollar of assets it utilizes for everyday operations.Health Ownership Allocation
Health and Plant has a total of 113.47 Million outstanding shares. Health retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 83.13 (percent) of Health outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Health Profitability Analysis
The company reported the revenue of 21 K. Net Loss for the year was (801 K) with profit before overhead, payroll, taxes, and interest of 6.08 M.About Health Valuation
The stock valuation mechanism determines Health's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Health and Plant based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Health. We calculate exposure to Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Health's related companies.Additional Tools for Health Stock Analysis
When running Health's price analysis, check to measure Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health is operating at the current time. Most of Health's value examination focuses on studying past and present price action to predict the probability of Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health's price. Additionally, you may evaluate how the addition of Health to your portfolios can decrease your overall portfolio volatility.